Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Endocrinology

The Classic Triad: Skin, Bones, and Hormones

At a Glance

McCune-Albright syndrome can affect the skin, bones, and hormone-producing glands, but a person may have only two of the classic features. Key signs include café-au-lait spots, fibrous dysplasia, and hormone-driven early puberty.

McCune-Albright Syndrome (MAS) is defined by a “classic triad” of three distinct features: unique skin spots, bone changes, and hormonal overactivity. However, because MAS is a mosaic condition, it is a “spectrum” disorder. You do not need to have all three signs to receive a diagnosis; in fact, many patients only show two [1][2].

1. Café-au-lait Macules: The “Coast of Maine”

For many families, the first sign of MAS is a birthmark. These are known as café-au-lait macules (French for “coffee with milk” because of their light brown color). While many people have simple birthmarks, the spots in MAS have very typical characteristics [3]:

  • Jagged Borders: Unlike the smooth, oval spots seen in other conditions like Neurofibromatosis (often called “Coast of California” borders), MAS spots typically have irregular, jagged edges, often compared to the “Coast of Maine” [3][4].
  • The Midline Rule: These spots often stop abruptly at the midline of the body (an imaginary line down the center of your chest or back). They frequently follow Blaschko’s lines, which are invisible paths that cells take as they grow in the womb [3][4].
  • Early Clues: These macules are often present at birth or appear very shortly after. They can serve as an early clue of where the GNAS mutation might be located, though appearance alone does not confirm MAS and a skin pattern does not reliably predict which bones or glands are affected [3].

2. Polyostotic Fibrous Dysplasia: Weakened Bone

In MAS, the genetic mutation affects the cells that build bone. This leads to Fibrous Dysplasia (FD), where healthy, hard bone is replaced by weaker, fibrous (scar-like) tissue [5]. When this occurs in multiple bones, it is called polyostotic [6].

  • “Ground-Glass” Appearance: On an X-ray or CT scan, these areas of fibrous tissue look hazy and grey, rather than the solid white of healthy bone. Radiologists call this a ground-glass matrix [5][6].
  • Structural Risks: Because this fibrous tissue is not as strong as typical bone, it can lead to several challenges:
    • Bone Pain: This is a common symptom, often described as a deep, aching sensation [7].
    • Fractures: Bones may break after only a minor injury because they are structurally compromised [8].
    • Deformities: Over time, weight-bearing bones (like the femur in the leg) can bow or bend. A classic example is the “shepherd’s crook” deformity of the hip [9].
  • Craniofacial Involvement: FD can also affect the skull. While often painless, it can sometimes put pressure on the nerves for vision or hearing, requiring specialized monitoring [10][11].

3. Autonomous Endocrine Hyperfunction: Hormonal Overdrive

The third part of the triad involves the glands. In MAS, the GNAS mutation keeps the “on” switch stuck in hormone-producing cells. This is autonomous, meaning the glands work on their own without waiting for a signal from the brain [12].

The most common hormonal sign, especially in girls, is precocious puberty (early puberty) [13]:

  • Ovarian Cysts: The ovaries may develop large, “functional” cysts that produce high levels of estrogen. These cysts often appear and disappear on their own [14][15].
  • Physical Signs: This estrogen “surge” can cause breast development or vaginal bleeding in very young children, sometimes even in infancy [12].
  • Growth Acceleration: These hormones tell the bones to grow quickly, making the child very tall for their age. However, they also cause the “growth plates” to close too early, which can lead to a shorter height in adulthood if not managed [16][12].
  • Gonadotropin-Independent: Unlike typical central puberty, which starts in the brain, MAS puberty is “peripheral” and starts in the ovaries (or testicles in boys) themselves. While boys can experience MAS-related early puberty from testicular lesions, it is more commonly recognized in girls [17]. Over time, recurrent peripheral sex-steroid exposure can trigger secondary central puberty.

By understanding these three typical signs, you and your care team can monitor the specific areas where the condition is active and create a proactive plan for individualized management.

Common questions in this guide

Can someone have McCune-Albright syndrome without all three classic features?
Yes. Because McCune-Albright syndrome affects some cells but not others, its features vary, and many people have only two parts of the classic triad. Doctors consider the overall pattern of skin, bone, and hormone findings rather than requiring all three.
What do the café-au-lait spots of McCune-Albright syndrome look like?
These light-brown birthmarks often have irregular, jagged edges called a “Coast of Maine” pattern. They may stop at the body’s midline and follow natural skin-cell growth lines, and they are often present at birth or soon after. Their appearance can raise suspicion but cannot confirm MAS or predict which bones or glands are affected.
What does fibrous dysplasia do to the bones in MAS?
In fibrous dysplasia, normal strong bone is replaced by weaker, scar-like tissue. Imaging may show a hazy “ground-glass” appearance, and affected bones can develop deep pain, fractures after minor injury, or bowing. When several bones are involved, it is called polyostotic fibrous dysplasia.
How does McCune-Albright syndrome cause early puberty?
In MAS, an ovary or testicle can produce sex hormones without waiting for the brain’s usual puberty signal. In girls, this may cause ovarian cysts, breast development, vaginal bleeding, and rapid growth at a young age; boys can also be affected. Repeated hormone exposure can later activate the usual brain-driven puberty process.
Do ovarian cysts and bleeding always mean a child has MAS?
No. Ovarian cysts and unexpected bleeding can have causes other than MAS, so these findings alone do not establish the diagnosis. A clinician should assess the child’s full history, examination, hormone findings, and other possible explanations.
How is MAS-related early puberty different from typical central puberty?
MAS-related puberty is usually peripheral, meaning the ovaries or testicles begin making hormones independently of the brain. Typical central puberty begins with signals from the brain, although recurrent hormone exposure in MAS can later activate that pathway. Clinicians distinguish them by considering where the hormone activity begins and the child’s pattern of physical changes.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on McCune-Albright syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do the jagged borders of my child's skin spots support a clinical diagnosis of MAS, or do we still need to look for other signs?
  2. 2.If my daughter has an ovarian cyst and bleeding, is this always caused by MAS, or could it be something else?
  3. 3.What is the 'bone age' and how does it help you understand how MAS is affecting growth?
  4. 4.Is the 'ground-glass' appearance on the X-ray localized to one bone, or should we be screening other areas for polyostotic involvement?
  5. 5.How do you differentiate 'peripheral' precocious puberty from the 'central' type that other children get?

References

References (17)
  1. 1

    Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

    Javaid MK, Boyce A, Appelman-Dijkstra N, et al.

    Orphanet journal of rare diseases 2019; (14(1)):139 doi:10.1186/s13023-019-1102-9.

    PMID: 31196103
  2. 2

    Craniofacial fibrous dysplasia and aneurismal bone cyst in a patient with McCune-Albright syndrome. A case report and review of the literature.

    Castro Castro J, Villa Fernández JM, Agulleiro Díaz JP

    Neurocirugia 2023; (34(5)):268-272 doi:10.1016/j.neucie.2022.09.002.

    PMID: 36192338
  3. 3

    [McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].

    Jung AJ, Soskin S, Paris F, Lipsker D

    Annales de dermatologie et de venereologie 2016; (143(1)):21-6.

    PMID: 26610360
  4. 4

    McCune-Albright syndrome - A case report with transmission electron microscopy.

    Garcia Neto V, de Almeida HL, Lorea CF, et al.

    Anais brasileiros de dermatologia 2022; (97(1)):58-62 doi:10.1016/j.abd.2021.09.002.

    PMID: 34839987
  5. 5

    Fibrous dysplasia of bone: craniofacial and dental implications.

    Burke AB, Collins MT, Boyce AM

    Oral diseases 2017; (23(6)):697-708 doi:10.1111/odi.12563.

    PMID: 27493082
  6. 6

    Imaging of Fibrous Dysplasia: A Comprehensive In-Depth Analysis of Monostotic, Polyostotic, Syndromic Forms, and Bone Sarcoma Development.

    Spinnato P, Marrone N, Romeo D, et al.

    Journal of imaging 2026; (12(6)) doi:10.3390/jimaging12060241.

    PMID: 42346904
  7. 7

    [Fibrous dysplasia].

    Waltermann A, Westhoff B

    Orthopadie (Heidelberg, Germany) 2024; (53(10)):805-816 doi:10.1007/s00132-024-04548-w.

    PMID: 39235640
  8. 8

    Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.

    Utriainen P, Valta H, Björnsdottir S, et al.

    Frontiers in endocrinology 2018; (9()):96 doi:10.3389/fendo.2018.00096.

    PMID: 29599748
  9. 9

    Changing Pattern of Femoral Deformity During Growth in Polyostotic Fibrous Dysplasia of the Bone: An Analysis of 46 Cases.

    Ippolito E, Valentini MB, Lala R, et al.

    Journal of pediatric orthopedics 2016; (36(5)):488-93 doi:10.1097/BPO.0000000000000473.

    PMID: 25887818
  10. 10

    McCune-Albright syndrome with craniofacial dysplasia: Clinical review and surgical management.

    Belsuzarri TA, Araujo JF, Melro CA, et al.

    Surgical neurology international 2016; (7(Suppl 6)):S165-9 doi:10.4103/2152-7806.178567.

    PMID: 27057395
  11. 11

    Otalgia revealing McCune-Albright syndrome: A case report.

    Sbai AA, Es-Salhi F, Tsen AA, Fahd Elayoubi

    Annals of medicine and surgery (2012) 2022; (82()):104706 doi:10.1016/j.amsu.2022.104706.

    PMID: 36268423
  12. 12

    Peripheral precocious puberty in girls with McCune-Albright syndrome: a case series.

    Faria AG, Montenegro LR, Jorge AAL, et al.

    Archives of endocrinology and metabolism 2025; (69(2)):e240459 doi:10.20945/2359-4292-2024-0459.

    PMID: 40366083
  13. 13

    McCune-Albright syndrome, a rare form of precocious puberty: Diagnosis, treatment, and follow-up.

    Gryngarten M, Comar H, Arcari A, et al.

    Archivos argentinos de pediatria 2021; (119(5)):e420-e427 doi:10.5546/aap.2021.eng.e420.

    PMID: 34569743
  14. 14

    Gynecologic and reproductive outcomes in fibrous dysplasia/McCune-Albright syndrome.

    Boyce AM, Casey RK, Ovejero Crespo D, et al.

    Orphanet journal of rare diseases 2019; (14(1)):90 doi:10.1186/s13023-019-1057-x.

    PMID: 31036049
  15. 15

    Clinical course of peripheral precocious puberty in girls due to autonomous ovarian cysts.

    Heo S, Shim YS, Lee HS, Hwang JS

    Clinical endocrinology 2024; (100(1)):29-35 doi:10.1111/cen.14943.

    PMID: 37386805
  16. 16

    Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.

    Estrada A, Boyce AM, Brillante BA, et al.

    European journal of endocrinology 2016; (175(5)):477-483 doi:10.1530/EJE-16-0526.

    PMID: 27562402
  17. 17

    Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty.

    Kang E, Cho JH, Choi JH, Yoo HW

    Annals of pediatric endocrinology & metabolism 2016; (21(3)):136-142 doi:10.6065/apem.2016.21.3.136.

    PMID: 27777905

This page explains the skin, bone, and hormone features of McCune-Albright syndrome for informational purposes only and does not constitute medical advice. A clinician should interpret your child’s findings, imaging, growth, and hormone changes and guide diagnosis and monitoring.